Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial. [electronic resource]
Producer: 20070103Description: 493-500 p. digitalISSN:- 0902-4441
- Adult
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Lymphoma -- drug therapy
- Male
- Middle Aged
- Neutrophils -- drug effects
- Peripheral Blood Stem Cell Transplantation -- methods
- Placebos
- Prospective Studies
- Recombinant Proteins
- Time Factors
- Transplantation, Autologous -- methods
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.